GX Genomics & Biotechnology ETF
(GNOM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNOM | ||||
| Company | GX Genomics & Biotechnology ETF | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 45.85 | ||||
| High | 46.20 | ||||
| Low | 45.25 | ||||
| Latest | 46.13 | ||||
| Change | +1.03 | ||||
| % Change | +2.28% | ||||
| Volume | 7,500 | ||||
| 20-Day Average Volume | 9,290 | ||||
| Previous Close | 45.10 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 48.05 | ||||
| 20-Day Raw Stochastic | 16.56% | ||||
| 20-Day Relative Strength | 45.86 | ||||
| Weighted Alpha | +25.97 | ||||
| Today's Opinion | 56% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.27% since 01/30/26 | ||||
| Low | 45.08 on 02/05/26 | ||||
| High | 48.31 on 02/03/26 | ||||
| 1-Month | |||||
| %Chg | -3.55% since 01/06/26 | ||||
| Low | 45.08 on 02/05/26 | ||||
| High | 51.42 on 01/22/26 | ||||
| 3-Month | |||||
| %Chg | +7.68% since 11/06/25 | ||||
| Low | 41.60 on 11/07/25 | ||||
| High | 51.42 on 01/22/26 | ||||
| 6-Month | |||||
| %Chg | +32.33% since 08/06/25 | ||||
| Low | 34.48 on 08/07/25 | ||||
| High | 51.42 on 01/22/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 50,282 | ||||
| Shares Outstanding, K | 1,090 | ||||
| Annual Sales | 19,340,000 | ||||
| Annual Net Income | -72,340,000 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.22 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | 03/19/13 | ||||
| Most Recent Dividend | 0.591 on 12/30/25 | ||||
| Next Ex-Dividends Date | 12/30/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | -17.21 | ||||